[EN] PROCESS FOR THE SYNTHESIS OF BASE ADDITION SALTS OF 2,3-0-ISOPROPYLIDENE-1-0-SUBSTITUTED-5,6-DIDEOXY-5-N- (4-(2-HYDROXY-2-OXOETHYL)-PHENYLAMINOCARBONYL) AMINO-L-GULOFURANOSIDES [FR] PROCEDE DE SYNTHESE DES SELS D'ADDITION DE BASE DE 5,6-DIDEOXY-5-N-(4-(2-HYDROXY-2-OXOETHYL)-PHENYLAMINOCARBONYL) AMINO-L-GULOFURANOSIDES SUBSTITUES PAR 2,3-0-ISOPROPYLIDENE-1-0
DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS
申请人:RANBAXY LABORATORIES, LTD.
公开号:EP1144425A1
公开(公告)日:2001-10-17
[EN] DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS<br/>[FR] DERIVES DE MONOSACCHARIDES EN TANT QU'INHIBITEURS DE L'ADHESION CELLULAIRE
申请人:RANBAXY LAB LTD
公开号:WO2000042053A1
公开(公告)日:2000-07-20
The present application relates to a group of novel substituted pentose and hexose monosaccharide derivatives, not previously disclosed, which exhibit potent anti-cell adhesion and anti-inflammatory activities. Methods of preparation, pharmaceutical compositions containing the compounds and methods of treatment, suppression and prevention of cell adhesion mediated chronic inflammatory disorders are also described.
[EN] MONOSACCHARIDE DERIVATIVES<br/>[FR] DERIVES DE MONOSACCHARIDE
申请人:RANBAXY LAB LTD
公开号:WO2005092907A2
公开(公告)日:2005-10-06
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection or psoriasis. Pharmacological compositions containing compounds disclosed herein and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, and other inflammatory and/or autoimmune disorders, using the compounds are also provided.
[EN] MONOSACCHARIDE DERIVATIVES<br/>[FR] DERIVES DU MONOSACCHARIDE
申请人:RANBAXY LAB LTD
公开号:WO2005100373A2
公开(公告)日:2005-10-27
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis or allergic rhinitis. Pharmacological compositions containing the compounds of the present invention and the methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis or allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.
[EN] PREPARATION OF MONOSACCHARIDE DERIVATIVES<br/>[FR] PREPARATION DE DERIVES DE MONOSACCHARIDE
申请人:RANBAXY LAB LTD
公开号:WO2004071515A1
公开(公告)日:2004-08-26
Process for the preparation of monosaccharide derivatives, providing industrial advantages, including convenience, safety, and economic advantages. The monosaccharide derivatives can be used for the inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies.